drugset / Trial / NCT01875107

Insulin Pre-treatment for Steroid-associated Hyperglycemia in Pregnant Diabetic Patients

NCT01875107

Phase 4 Withdrawn University of Minnesota
NaSingle-groupOpen-labelTreatment

Summary

Our objective is to assess whether pre-treatment with a fixed dose of insulin, based on weight, given to pregnant patients with gestational or preexisting diabetes receiving betamethasone can provide adequate glycemic control. Our hypothesis is that pre-treatment with a weight-based calculated insulin dose will help maintain euglycemia for pregnant patients with gestational and preexisting diabetes after steroid administration, and possibly impact length of hospital admission.

Timeline

Start
2013-08
Primary completion
2014-08
Completion
2014-08

Drugs

EvaluationDrugModalityDoseRoute
Subject Insulin Protein / enzyme biologic

Indications